• Effect of the market withdrawal of dextropropoxyphene on use of other prescribed analgesics 

      Reset, Askild; Skurtveit, Svetlana; Furu, Kari; Skovlund, Eva (Journal article; Peer reviewed, 2018)
      Background and aims Dextropropoxyphene (DXP) is a synthetic opioid that was prescribed worldwide for mild to moderate pain. It was withdrawn from the European market in 2009. In this study we aim to investigate the effect ...
    • Risk factors for stroke and choice of oral anticoagulant in atrial fibrillation 

      Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine Holtermann; Furu, Kari; Skovlund, Eva (Journal article; Peer reviewed, 2018)
      Purpose To investigate risk factors for stroke in patients initiating oral anticoagulants for atrial fibrillation in Norway and their association with receiving DOACs versus warfarin. Methods From nationwide registries, ...
    • Trends in use of warfarin and direct oral anticoagulants in atrial fibrillation in Norway, 2010 to 2015 

      Kjerpeseth, Lars Jøran; Ellekjær, Hanne; Selmer, Randi; Ariansen, Inger Kristine; Furu, Kari; Skovlund, Eva (Journal article; Peer reviewed, 2017)
      Purpose Since 2011, several direct oral anticoagulants (DOACs; dabigatran, rivaroxaban, apixaban) have been introduced as alternatives to warfarin for stroke prophylaxis in atrial fibrillation. We wanted to investigate ...